Heart Failure With Preserved Ejection Fraction (HFpEF) (DBCOND0067171)

Identifiers

Synonyms
Heart Failure, Preserved Ejection Fraction / HFpEF - Heart Failure With Preserved Ejection Fraction / Heart Failure With a Preserved Ejection Fraction / Heart Failure With Preserved Ejection Fraction / Heart Failure Preserved Ejection Fraction / Diastolic (congestive) heart failure / Heart failure with normal ejection fraction (disorder) / Unspecified diastolic (congestive) heart failure / Heart Failure, Diastolic / Diastolic heart failure (disorder) / Diastolic heart failure / Left ventricular failure, unspecified / Left ventricular failure / Left ventricular failures / LVF / Left ventricular insufficiency / Failure heart left / Left heart failure / Heart Failure, Left-Sided / Left heart failure (disorder) / Cardiac failure left / Left cardiac failure / Failure left heart

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06350487
The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fractiontreatment4not_yet_recruiting
NCT05638230
Relative Importance of Cardiovascular Risk Factors and Echocardiographic Parameters Affecting Left Atrial StrainNo drug interventionsNot AvailableNot Availablerecruiting
NCT03197350
Characterization of Heart Failure With Preserved Ejection FractionNo drug interventionsotherNot Availablerecruiting
NCT05745337
Atrial Fibrillation: Chronic Beta-blocker Use Versus As-needed Rate Control Guided by Implantable Cardiac Monitortreatment1recruiting
NCT04826159
IMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpEF (Pt 2)No drug interventionstreatment2recruiting
NCT06312748
Novel Approaches for Improving Vascular Function in Veterans With HFpEFtreatment1recruiting
NCT06405126
Validation of a Machine Learning Predictive Model to Distinguish Post-capillary Pulmonary HypertensionNo drug interventionsNot AvailableNot Availablerecruiting
NCT05784753
HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection FractionNo drug interventionstreatmentNot Availablerecruiting
NCT05637398
Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fractiontreatment1 / 2recruiting
NCT06125925
Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)No drug interventionstreatmentNot Availablerecruiting
NCT06514820
Exercise Magnetic Resonance Imaging in Patients With Obesity Associated Heart FailureNo drug interventionsNot AvailableNot Availablerecruiting
NCT05610410
Peripheral Microvascular Blood Flow in ANOCANo drug interventionsNot AvailableNot Availablerecruiting
NCT02145351
Efficacy Study of Pacemakers to Treat Slow Heart Rate in Patients With Heart FailureNo drug interventionstreatmentNot Availablecompleted
NCT04434664
BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEFtreatment4recruiting
NCT05826821
Biomarkers in HF: Circulating Biomarkers of Fibrosis and Cardiovascular DiseaseNot AvailableNot Availablecompleted
NCT05312021
Selective PDE9 Inhibition With IMR-687 in Adults With Heart Failure With Preserved Ejection Fractiontreatment2withdrawn
NCT04986202
Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%treatment2 / 3completed
NCT03057002
UTSW HP [13-C] Pyruvate Injection in HCMNo drug interventionsNot AvailableNot Availablerecruiting
NCT06080802
The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fractiontreatment2 / 3not_yet_recruiting
NCT04757584
Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEFother4completed
NCT02901184
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fractiontreatment3recruiting
NCT05991284
Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Valve Regurgitationtreatment4recruiting
NCT05723679
Targeting Breathing Limitations to Improve Functional Outcomes in HFpEFNo drug interventionsotherNot Availablerecruiting
NCT03351179
Predictors and Outcomes of In-hospital HFpEF in AMI PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04063579
Cardiac Magnetic Resonance Assessment for Heart Failure With Preserved Ejection FractionNo drug interventionsdiagnosticNot Availablecompleted
NCT05649787
Effects of a Supervised Training Program on Functional Capacity in Patients With HFpEF and Chronotropic IncompetenceNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05838287
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participantstreatment4recruiting
NCT05600387
Empagliflozin on the Function of Left Atrium in Heart Failure With Mildly Reduced or Preserved Ejection Fractiontreatment4enrolling_by_invitation
NCT03340233
Understanding the Mechanisms of Diastolic DysfunctionNo drug interventionsdiagnosticNot Availablewithdrawn
NCT04970953
Diastolic Exercise Stress Testing in Heart FailureNo drug interventionsNot AvailableNot Availableterminated
NCT04998877
Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects and HFpEF PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02078947
Optimizing Exercise Training in Prevention and Treatment of Diastolic Heart FailureNo drug interventionstreatmentNot Availablecompleted
NCT06369298
Study of JK07 in Patients With Chronic Heart FailureNo drug interventionstreatment2recruiting
NCT04913805
Matching Perfusion and Metabolic Activity in HFpEFtreatment2recruiting
NCT05715697
Renal Denervation in Patients With Chronic Heart Failure With Preserved Ejection FractionNo drug interventionstreatmentNot Availablerecruiting
NCT04767061
Impact of Beta-blockers on Physical Function in HFpEFother4completed
NCT05991128
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Lifetreatment4recruiting
NCT05839028
Mechanisms of LV Remodeling in Hypertensive Patients Working on a Rotational Expeditionary Basis in the ArcticNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03153111
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Diseasetreatment2completed
NCT01920711
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fractiontreatment3completed
NCT06101693
Biomarkers in Patients With Suspected HFpEFNo drug interventionsNot AvailableNot Availablerecruiting
NCT05219188
PErirenal Adipose Tissue and RenaL Hemodynamics in Patients With Heart Failure With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availableunknown_status
NCT05828888
CHIP in Endothelial Dysfunction Associated With HEpEFNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06208007
Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEFNo drug interventionsNot AvailableNot Availablerecruiting
NCT06228807
Clinical Characteristics and Predictors of Adverse Outcomes in HFpEFNo drug interventionsNot AvailableNot Availablecompleted
NCT04239807
3-Month Home-based Training With Whole Body Vibration (WBV) Device in Patients With Heart Failure and Preserved Ejection Fraction (GALILEO-HFpEF-HOME) (GALILEOHOME)No drug interventionstreatmentNot Availableunknown_status
NCT04945707
Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)treatment4recruiting
NCT05064709
Assessment of CCM in HF With Higher Ejection FractionNo drug interventionstreatmentNot Availablerecruiting
NCT04820556
Gut Microbiota in Chronic Noncommunicable DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT05053256
The Relationship Between Heart Function and Metabolism in HFpEF PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05508256
CAtheter-Based Ablation of Atrial Fibrillation Compared to Conventional Treatment in Patients With Heart Failure With Preserved Ejection FractionNo drug interventionstreatment4recruiting
NCT03254485
A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF)treatment2completed
NCT04739215
Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEFtreatment4unknown_status
NCT06309537
Chemoreflex Sensitivity in HFpEFNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06201832
Cardiac Amyloidosis in HFpEF Tunisian PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04404452
Heart Failure Monitoring With Eko Electronic StethoscopesNo drug interventionsNot AvailableNot Availableterminated
NCT03226652
Heart Function in Patients Assessed for Sleep ApnoeaNo drug interventionsNot AvailableNot Availablecompleted
NCT05093959
Metformin for Older Patients With Heart Failure With Preserved Ejection Fractiontreatment2recruiting
NCT05002075
Efficacy of an m-Health Cardiac Rehabilitation Program in Heart Failure With Preserved Ejection FractionNo drug interventionstreatmentNot Availablecompleted
NCT03837470
Evaluation of Renal Sodium Excretion After Salt Loading in Heart Failure With Preserved Ejection Fractionbasic_science0completed
NCT06510270
Dapagliflozin in Reducing Epicardial Adipose Tissue in Heart Failure with Preserved Ejection FractionNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05159570
Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Metabolic Effects. (KETO-HFpEF-Metabolic)No drug interventionstreatmentNot Availablecompleted
NCT05279742
Enhancing the Natriuretic Peptide System in HFpEFtreatment1 / 2enrolling_by_invitation
NCT04235699
Ketogenic Diet in Patients With Heart FailureNo drug interventionstreatmentNot Availableterminated
NCT04506606
Cardiac Rehab Effects in HFpEFNo drug interventionstreatmentNot Availablerecruiting
NCT05057806
SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Planbasic_science0recruiting
NCT06486649
Application of Multimodal Large Language Model in HFpEFNo drug interventionsNot AvailableNot Availablerecruiting
NCT04886713
Adipose Tissue Inflammation in HFpEFNo drug interventionsNot AvailableNot Availableunknown_status
NCT04745013
PeRsonalIzed remOtely Guided Preventive exeRcIse Therapy for a healThY HeartNo drug interventionspreventionNot Availablerecruiting
NCT03619213
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.treatment3completed
NCT01354613
Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)treatmentNot Availablecompleted
NCT04019613
Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress TestingNo drug interventionsdiagnosticNot Availableterminated
NCT05584319
EMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection Fractiontreatment4enrolling_by_invitation
NCT05651919
PBMC as Biomarkers of Diabetic CardiomyopathyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06532019
Clinical Study of Active Intervention in High-risk HFpEF PatientsNo drug interventionsotherNot Availablenot_yet_recruiting
NCT04064541
Virtual Visits to Optimize Research Trial Offerings to HF PatientsNo drug interventionshealth_services_researchNot Availablecompleted
NCT04964817
HFpEF and Symptomatic Obstructive Iliofemoral Venous Disease StudyNo drug interventionsNot AvailableNot Availableterminated
NCT05322616
Single-Ascending Dose Study of JK07 in Subjects With HFpEFNo drug interventionstreatment1withdrawn
NCT03550235
Exploration of Dyspnea at Non-high Brain Natriuretic Peptide (BNP)No drug interventionsNot AvailableNot Availableunknown_status
NCT04398563
Heart Failure in Norway: Clinical Characteristics, Mortality and Health Care Resource UseNo drug interventionsNot AvailableNot Availableunknown_status
NCT00840463
Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentandiagnostic4terminated
NCT05496439
Study of the Prognosis of Patients With Heart Failure With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablecompleted
NCT06282822
Shear Wave Elastography for Diagnosis of Heart Failure With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05822622
Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05585125
A Preliminary Study for INFORMEDNo drug interventionsother4recruiting
NCT03160625
Evaluation of Rate Adaptive Pacing on Chronotropic Response in Preserved Ejection Fraction HFNo drug interventionstreatmentNot Availablewithdrawn
NCT05376748
Exercise Capacity Before and After AF Ablation in Patients With HFpEFNo drug interventionsNot AvailableNot Availablerecruiting
NCT04535726
The Relationship Between Blood Pressure and Arterial Stiffness in HFpEF Patients With Different Levels of ObesityNo drug interventionsNot AvailableNot Availablecompleted
NCT05731466
Exercise Right Ventricular Coupling in HFpEFNo drug interventionsdiagnosticNot Availablerecruiting
NCT01288365
The Impact of Exercise Training on Functional Capacity in Heart FailureNo drug interventionstreatmentNot Availableunknown_status
NCT05953831
Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac HypertrophyNo drug interventionstreatment2withdrawn
NCT04862273
Native T1 CMR Imaging for Diagnosis of Cardiac AmyloidosisNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04788576
Distribution and Clinical Implication of CMD in Patients With HFpEF Without Significant CADNo drug interventionsNot AvailableNot Availablerecruiting
NCT06015776
Purinergic Signaling and the Postmenopausal HeartNo drug interventionsNot AvailableNot Availablerecruiting
NCT05752760
Pilot Study Lp299v Supplementation in Chronic Heart FailureNo drug interventionsbasic_scienceNot Availablerecruiting
NCT05393362
Effectiveness of a Cardiac Rehabilitation Program in Elderly Patients With Heart Failure.No drug interventionstreatmentNot Availablerecruiting
NCT03037580
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fractiontreatment3terminated
NCT04644692
Effort-Lung Ultra SoundNo drug interventionsNot AvailableNot Availablecompleted
NCT05582044
Exercise Lower-body Negative Pressure in Heart Failure With Preserved Ejection FractionNo drug interventionstreatmentNot Availablerecruiting
NCT04237701
Real-Time Monitoring of Heart Failure Across the Yale New Haven Health SystemNo drug interventionsNot AvailableNot Availablerecruiting
NCT05490901
The Prognostic Role and Diagnostic Efficacy of Exercise Right Heart Catheterization With a Simultaneous Echocardiography in Patients With Dyspnea on ExertionNo drug interventionsNot AvailableNot Availablerecruiting
NCT03066804
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patientstreatment3completed
NCT05139472
Impact of Empagliflozin on Functional Capacity in Heart Failure With Preserved Ejection Fractiontreatment3completed
NCT04894968
Prediction of the Development of Heart Failure With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availableunknown_status
NCT02053246
Improving Treatment Personalization of Pulmonary Hypertension Associated With Diastolic Heart Failuretreatment4terminated
NCT04395846
Heart Failure and Preserved Ejection Fraction: Observation of Its Progression and Prognosis (HOPP-BERN)No drug interventionsNot AvailableNot Availablerecruiting
NCT06046612
Empagliflozin for Peripheral Microvascular Dysfunction in Heart Failure With Preserved Ejection Fractiontreatment4recruiting
NCT05878912
The Effect of Obesity and Weight Loss in Heart Failure With Preserved Ejection FractionNo drug interventionstreatmentNot Availablerecruiting
NCT03506412
Circulating NEP and NEP Inhibition Study in Heart Failure With Preserved Ejection Fractiontreatment4completed
NCT05833581
Consistently Assess Signs and Symptom of Heart FailureNo drug interventionsotherNot Availablerecruiting
NCT05553314
Carvedilol in HF With Preserved EFtreatment4recruiting
NCT04424914
Global Prevalence of ATTR-CM in Participants With HFpEFNo drug interventionsscreeningNot Availableterminated
NCT06353750
Intracellular Magnesium and Heart FailureNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05796050
Sex Related Differences in Cardiac FunctionNo drug interventionsNot AvailableNot Availablerecruiting
NCT06309550
Provocative Tests for HFpEFNo drug interventionsNot AvailableNot Availablerecruiting
NCT06576050
WeighT LOSS Surgery and Comprehensive Cardiometabolic Responses to to EXerciseNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05464238
Training in HFpEF-PHNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06465043
HFPEF-project: Heart Failure Phenotyping - Exploring the FingerprintsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06081543
Ketogenic Diet vs Mixed Diet in Patients With Heart FailureNo drug interventionsbasic_scienceNot Availablerecruiting
NCT05676684
Dapagliflozin With or Without Spironolactone for HFpEFtreatment2 / 3active_not_recruiting
NCT01505179
The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection FractiontreatmentNot Availablecompleted
NCT05030987
Renal Denervation to Treat Heart Failure With Preserved Ejection FractionNo drug interventionstreatmentNot Availablerecruiting
NCT05058833
Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular FunctionNo drug interventionsNot AvailableNot Availableunknown_status
NCT05174351
Beta-blocker Discontinuation in Heart Failure With Preserved Ejection FractionNo drug interventionstreatmentNot Availableunknown_status
NCT05753553
Incidence and Echocardiographic Predictors of HFpEF in High-Risk Population Afferent to Italian Echo-labs NetworkNo drug interventionsNot AvailableNot Availablerecruiting
NCT05789147
Transcutaneous Vagus Nerve Stimulation in Heart FailureNo drug interventionstreatmentNot Availablerecruiting
NCT04730947
Dapagliflozin (DAPA) Effects in HFpEFtreatment2completed
NCT04592445
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEFNo drug interventionstreatmentNot Availableunknown_status
NCT04318145
Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjectstreatment2unknown_status
NCT06249945
EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Diseasetreatment4not_yet_recruiting
NCT06114498
Hospital Register of Decompensated Heart Failure With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablerecruiting
NCT06576297
Novel Respiratory Training as Part of Palliative Care for Older Adults With Heart FailureNo drug interventionstreatmentNot Availablerecruiting
NCT05409183
Effectiveness of CRD-740 in Heart FailureNo drug interventionstreatment2terminated
NCT06078683
Effects of Ketone Ester Consumption on Exercise Tolerance and Cardiac FunctionNo drug interventionsbasic_scienceNot Availablerecruiting
NCT06377761
Study on Heart Failure With Preserved Ejection Fraction With Qishen GranulesNo drug interventionstreatmentNot Availablerecruiting
NCT04163861
Frequency and Magnitude of Subclinical Systolic Dysfunction by Strain Imaging in Heart Failure With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablecompleted
NCT04455828
Wearable Remote Monitoring of Heart Rate and Respiratory Rate for Heart FailureNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05586828
A Single-center Retrospective Cohort Study to Explore the Prognostic Significance of CONUT in Elderly CAD Patients With HFpEFand Compare CONUT With Other Objective Nutritional Indices.No drug interventionsNot AvailableNot Availablecompleted
NCT05122793
"HerzCheck" - Detection of Early Heart Failure Using Telemedicine in Structurally Weak RegionsNo drug interventionspreventionNot Availableactive_not_recruiting
NCT05887271
A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection FractionNo drug interventionstreatment2 / 3recruiting
NCT05888688
The Sarcopenia StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05095688
Relationship Between Adipose Tissue Distribution and Arterial Stiffness in HFpEFNo drug interventionsNot AvailableNot Availableunknown_status
NCT06027307
Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitationtreatment3recruiting
NCT06536309
Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection Fractiontreatment4not_yet_recruiting
NCT05114785
Heart Failure With Preserved Ejection Fraction: Evaluation and Recognition by CMRNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06409585
Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis TransitionNo drug interventionsNot AvailableNot Availablerecruiting
NCT05556785
Association of Epicardial Adipose Tissue Volume Axnd Radiodensity With Coronary Artery Calcification in Patients With HFpEFNo drug interventionsNot AvailableNot Availableunknown_status
NCT03948685
Carvedilol SR Study for Biomarkers From Blood and Urine and Safety of in Patients With Heart Failure With Preserved Ejection Fractiontreatment4unknown_status
NCT05338437
NMES in HF Patients to Improve Functional Recovery Following HospitalizationNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT03414632
Transthyretin Cardiac Amyloidosis in HFpEFNo drug interventionsdiagnostic0completed
NCT06379152
Effect of Bilirubin on Prognosis in Heart Failure With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablerecruiting
NCT06311552
Optimising CMR Scan Acquisitions for Novel Equipment/Sequences in Clinical Cardiovascular Populations.No drug interventionsNot AvailableNot Availablecompleted
NCT05795400
Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid CardiomyopathytreatmentNot Availablerecruiting
NCT06581159
Study of HS135 in Obese Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection FractionNo drug interventionstreatment1not_yet_recruiting
NCT05592275
A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)No drug interventionstreatment2recruiting
NCT05138575
SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trialtreatment2recruiting
NCT04594499
The Relationship Between Pericardial Fat Thickness and Arterial Stiffness in HFpEF PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01932606
Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fractiontreatment2completed
NCT04281849
Balance, Aerobic Capacity, Mobility and Strength in Patients Hospitalized for Heart Failure (BAMS-HF) ProgramNo drug interventionstreatmentNot Availablecompleted
NCT06061549
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Preserved Ejection FractionNo drug interventionstreatment1recruiting
NCT04505449
Invasive Left Heart Catheterization RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT06081049
The COLchicine HEART Failure PRESERVED Trial (COLHEART-PRESERVED)treatment2recruiting
NCT04112849
Electronic S3 Prediction of Hospital Readmissions for HF ExacerbationNo drug interventionsNot AvailableNot Availablecompleted
NCT04153136
Effects of Sacubitril/Valsartan on Subclinical Heart Failure in HIV (The ENCHANTMENT HIV Study)treatment2recruiting
NCT04111536
Developing Oral LT3 Therapy for Heart Failure - HFpEFtreatment1 / 2completed
NCT05126836
Cilostazol for HFpEFtreatment2completed
NCT05236413
The Effect of a High Fiber Diet and High-Intensity Interval Exercise in Patients With HFpEFNo drug interventionssupportive_careNot Availablerecruiting
NCT05284617
Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEFNo drug interventionstreatment2completed
NCT05672134
Evaluation of GeranylGeranylAcetone in Heart Failure With Preserved Ejection Fractiontreatment2enrolling_by_invitation
NCT05068934
The Relationship Between Epicardial Fat Tissue and Cardiac Function in HFpEF PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05873634
HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment TargetsNo drug interventionsNot AvailableNot Availablerecruiting
NCT06065124
Bariatric Surgery Evaluation and Assessment of Treatment Efficacy - Intervention TrialNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04327596
Radiofrequency (RF) Ablation for Atrial Fibrillation (AF) in Patients With Heart Failure With Preserved Ejection FractionNo drug interventionstreatmentNot Availableterminated
NCT05992558
Longitudinal Multimarker Risk Models for Very Elderly Patients With Heart Failure and Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablerecruiting
NCT05236335
Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Cardiovascular Effects.No drug interventionstreatmentNot Availablecompleted
NCT01411735
Evaluation of Enalapril Versus Placebo in Patients With Diastolic Heart Failuretreatment3completed
NCT05525663
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection FractionNo drug interventionstreatmentNot Availablerecruiting
NCT05562063
Sotagliflozin in Heart Failure With Preserved Ejection Fraction (HFpEF) Patientstreatment4recruiting
NCT05551663
Isometric Exercise Training in Participants With Heart Failure With Preserved Ejection FractionNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT06196086
Myocardial Stiffness Evaluation in Patients With Heart Failure With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablerecruiting
NCT06517186
Myocardial Mechanisms in Heart Failure With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablerecruiting
NCT04233086
Retrospective Observational Analysis of a Cohort With Heart Failure With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablecompleted
NCT04317339
The Efficacy and Safety of Zhigancao Tang Granule for HFpEF of Qi-Yin DificiencyNo drug interventionstreatment2unknown_status
NCT05089539
The Effect of Angiotensin Receptor-Neprilysin Inhibition on Cardiac Fibrosis in Patients With HFpEFtreatment2unknown_status
NCT05129722
Polydiuretic Therapy for HFpEF, a Randomised Controlled Trialtreatment4recruiting
NCT06567925
Sleep Extension to Improve Sleep Efficiency and QoL in HF With Preserved Ejection Fraction: the SLEEP-HF Pilot StudyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03923530
Pressure Assessment to Improve Outcomes After TAVR: a Registrytreatment0completed
NCT05839730
Fast Induced Remodeling in Heart Failure With Preserved Ejection FractionNo drug interventionstreatmentNot Availablesuspended
NCT03617848
Optimising Management of Patients With Heart Failure With Preserved Ejection Fraction in Primary CareNo drug interventionsNot AvailableNot Availablecompleted
NCT04587648
Cardiac Amyloidosis in HFpEFNo drug interventionsNot AvailableNot Availablerecruiting
NCT06388226
Leg Heat Therapy in Heart Failure With Preserved Ejection FractionNo drug interventionstreatmentNot Availablerecruiting
NCT04065620
Ambulatory Blood Pressure in HFPEF Outcomes Global RegistryNo drug interventionsNot AvailableNot Availableunknown_status
NCT00207220
Ventricular-Vascular Coupling in Heart FailureNo drug interventionsNot AvailableNot Availablecompleted
NCT06217120
Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fractiontreatment2 / 3not_yet_recruiting
NCT01047631
Role of Exercise in Diastolic Heart FailureNo drug interventionstreatmentNot Availablecompleted
NCT04727073
Spironolactone In The Treatment of Heart Failuretreatment3recruiting
NCT03960073
Chronic Kidney Disease and Heart Failure With Preserved Ejection Fraction: The Role of Mitochondrial DysfunctionNo drug interventionsotherNot Availablecompleted
NCT06479876
Home-Based Cardiac Rehabilitation for Patients With Heart FailureNo drug interventionstreatmentNot Availablerecruiting
NCT04632160
Extended IASD Investigation: REDUCE LAP-HF IVNo drug interventionstreatmentNot Availablewithdrawn
NCT04633460
Acute Effects of Exogenous Ketone Ester Administration in Heart FailureNo drug interventionstreatment2completed
NCT04835194
Phenotypes and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With Hypertension and DiabetesNo drug interventionsNot AvailableNot Availablecompleted
NCT01030991
Classification of Heart Failure With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablecompleted
NCT04113291
Randomized Controlled Pilot Trial of DASH Feeding in Older Low Socioeconomic Adults Without Heart FailureNo drug interventionspreventionNot Availablewithdrawn
NCT04391491
Neuregulin-1 in Patient With Different Forms of Cardiovascular Diseases: a Pilot StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT04128891
Study of Sacubitril/ValsarTan on MyocardIal OxygenatioN and Fibrosis in Heart Failure With Preserved Ejection Fractiontreatment3withdrawn
NCT05055180
Right Ventricular Function and Pulmonary Hypertension in HFpEFNo drug interventionsNot AvailableNot Availableunknown_status
NCT04175080
Clinical Significance and Diagnosis of Sarcopenia in Cardiac PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT06442280
SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HFtreatment4not_yet_recruiting
NCT04189029
PACIFIC-PRESERVED : PhenomApping, ClassIFication, and Innovation for Cardiac Dysfunction - HF With PRESERVED LVEF StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04766892
A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnTtreatment2completed
NCT06278844
Exercise Capacity Improvement by Conduction System Pacing in heArt Failure patieNts Without Compelling CRT inDicationNo drug interventionstreatmentNot Availablerecruiting
NCT01185067
Physiological Effects of Grape Seed Extract in Diastolic Heart Failuretreatment1completed
NCT01091467
Prospective Study of Heart Failure With Preserved Left Ventricular Ejection FractionNo drug interventionsNot AvailableNot Availablecompleted
NCT06487468
Risk Factors In Heart Failure Patients With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablecompleted
NCT05059769
Relationship Between Ambulatory Arterial Stiffness Index and Left Ventricular Diastolic Function in Patients With HFpEFNo drug interventionsNot AvailableNot Availableunknown_status
NCT05884346
Association Between Coronary and Peripheral Vascular Injury in Heart Failure Patients With Preserved Ejection Fraction.No drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT04287946
Endovascular GSN Ablation in Subjects With HFpEFNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT06337812
Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)No drug interventionshealth_services_researchNot Availablerecruiting
NCT06391710
HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection FractionNo drug interventionstreatment2recruiting
NCT01618981
LEft Atrial Pacing in Diastolic Heart FailureNo drug interventionsNot AvailableNot Availablecompleted
NCT05985395
HEART Camp Connect: A Feasibility StudyNo drug interventionshealth_services_researchNot Availablecompleted
NCT05719714
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Diseasetreatment1 / 2recruiting
NCT05824923
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart FailureNo drug interventionstreatment3recruiting
NCT06174623
Feasibility Study to Support Cardiorenal Function in Acute Decompensated Heart Failure With Diuretic ResistanceNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05204238
Follow Up of acuTe Heart failUre: a pRospective Echocardiographic and Clinical Study (FUTURE)No drug interventionsNot AvailableNot Availableunknown_status
NCT06401343
Use of SGLT2i in noHCM With HFpEFtreatment4recruiting
NCT03715543
Surgical Resection of the Greater Splanchnic Nerve in Subjects Having Heart Failure With Preserved Ejection FractionNo drug interventionstreatmentNot Availablecompleted
NCT05888233
Allopurinol Improves Heart Function in African Americans With Resistant Hypertensiontreatment2recruiting
NCT06215586
Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)treatment2recruiting
NCT02435667
Resistance Training in HFpEFNo drug interventionssupportive_careNot Availablecompleted
NCT06057623
Neuromuscular Fatigue and Exercise Capacity in Patients With Type 2 Diabetes Mellitus and HFpEFNo drug interventionsNot AvailableNot Availablerecruiting
NCT06467266
Mechanistic Insights From Temporary Pacing in HFpEFNo drug interventionsbasic_scienceNot Availablenot_yet_recruiting
NCT06338943
Middle-aged Women With Adverse Pregnancy Outcomes and Heart Failure With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablerecruiting
NCT05383287
Characteristics, Phenotypes, and TRAITS of Heart Failure With Preserved Ejection Fraction (TRAITS-HFpEF)No drug interventionsNot AvailableNot Availablerecruiting
NCT04232345
A Study to Assess the Effect AZD4831 in Japanese and Chinese Healthy Volunteerstreatment1completed
NCT05792059
DevElopMent of Clinical PATHwaYs to the Diagnosis of Heart Failure With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablerecruiting
NCT01989299
Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients With Heart Failure and Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablecompleted
NCT03988634
Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)treatment3completed
NCT03877224
DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection Fractiontreatment3completed
NCT04327024
Study of Verinurad in Heart Failure With Preserved Ejection Fractiontreatment2completed
NCT06036186
Study for the Treatment of Heart Failure With Preserved Ejection Fraction Associated With High Blood Pressure Using Right Atrial Pacing Controlled by the PressurePaceTM SystemNo drug interventionstreatmentNot Availablecompleted
NCT05441839
UK Heart Failure With Preserved Ejection FractionNo drug interventionsNot AvailableNot Availablerecruiting
NCT04847557
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trialtreatment3completed
NCT06560762
Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)No drug interventionstreatment1not_yet_recruiting
NCT03909295
An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan.treatment3terminated
NCT01714752
Evaluation of Left Ventricular Filling Pressures During ExerciseNo drug interventionsdiagnosticNot Availablecompleted
NCT04822649
Exercise Capacity According to Coronary Microvascular Dysfunction and Body CompositionNo drug interventionsdiagnosticNot Availablerecruiting
NCT05371496
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fractiontreatment2recruiting
NCT05136820
Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter StudyNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03843060
A Phase 1 Study to Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy Volunteerstreatment1completed
NCT03876223
Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEFNo drug interventionsNot AvailableNot Availablerecruiting